By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sistemic, an miRNA-based products developer, said today that it has received an undisclosed amount of funding from the economic development entity Scottish Enterprise.

The Glasgow-based company said that the grant is part of a £1 million ($1.5 million) investment campaign that it plans to use to double the size of its operations and to relocate to customized labs in the first half of this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.